The launch of phase 1 Ebola vaccine studies is a first step in developing a vaccine that could be licensed and used in the field to protect not only the front line health care workers but also those living in areas where Ebola virus exists.

The world is a place that is so interconnected that what happens in another part of the world will impact us.

One of the by-products of being a perfectionist and constantly trying to improve myself are sobering feelings of low-grade anxiety and a nagging sense of inadequacy This anxiety keeps me humble.

There cannot be any impediment to science that will ultimately be good to the general public.

Exposures, if they are mild, in the sense of barely just a small concentration, it's mostly an irritant, particularly the peroxides, that in that smoke would irritate the skin or even irritate the lungs. So, for the most time, it could be either just a little bit of a nuisance irritant, or if you get a really big whiff of it, particularly people who have, for example, reversible airways disease, like asthma or different types of hypersensitivity diseases, you could get a serious problem.

I run a modest-sized laboratory thats looking specifically at what we call the pathogenic mechanisms of HIV disease, or AIDS.

Previous efforts to eradicate malaria failed for several reasons, including political instability and technical challenges in delivering resources, especially in certain countries in Africa.